Home › Companies › Edwards Lifesciences Corporation › 2025-2026
Compiled from SEC Form N-PX filings and Edwards Lifesciences Corporation’s Form 8-K, filed 2026-05-08 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore Edwards Lifesciences Corporation in the interactive database Compare manager voting policies
These tallies are Edwards Lifesciences Corporation’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-05-08 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Leslie C. Davis | 461,819,765 | 13,184,241 | 881,733 | -- | 27,211,476 | Majority: yes |
| Elect Director: David T. Feinberg, MD | 473,746,144 | 1,812,520 | 327,076 | -- | 27,211,476 | Majority: yes |
| Elect Director: Kieran T. Gallahue | 457,045,403 | 18,518,195 | 322,142 | -- | 27,211,476 | Majority: yes |
| Elect Director: Leslie S. Heisz | 454,955,195 | 20,567,869 | 362,676 | -- | 27,211,476 | Majority: yes |
| Elect Director: Paul A. LaViolette | 428,701,646 | 45,445,276 | 1,738,817 | -- | 27,211,476 | Majority: yes |
| Elect Director: Steven R. Loranger | 446,216,434 | 28,909,945 | 759,361 | -- | 27,211,476 | Majority: yes |
| Elect Director: Ramona Sequeira | 474,260,552 | 1,295,682 | 329,506 | -- | 27,211,476 | Majority: yes |
| Elect Director: Nicholas J. Valeriani | 441,224,095 | 34,327,820 | 333,825 | -- | 27,211,476 | Majority: yes |
| Elect Director: Bernard J. Zovighian | 459,179,727 | 16,257,009 | 449,004 | -- | 27,211,476 | Majority: yes |
| Proposal 2: The advisory proposal regarding the Company's named executive officer compensation was approved as set forth below: | 424,961,639 | 50,924,101 | 0 | -- | 27,211,476 | Majority: yes |
| Proposal 3: Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 was approved as set forth below: | 446,283,142 | 56,814,075 | 0 | -- | 27,211,476 | Majority: yes |
| Proposal 4: The approval of the Company's Amended and Restated Long-Term Stock Incentive Compensation Program was approved as set forth below: | 456,675,201 | 19,210,539 | 0 | -- | 27,211,476 | Majority: yes |
Source: Edwards Lifesciences Corporation, Form 8-K, filed with the SEC on 2026-05-08 — read the filing on EDGAR.
Each item below shows how the 1,050 asset managers that disclosed a Edwards Lifesciences Corporation vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Edwards Lifesciences Corporation’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Meeting held 2026-05-07.
Combines 13 wordings of this item as funds reported it.
89% Majority: yes · of votes cast
Edwards Lifesciences Corporation’s own tally for this item (“Proposal 2: The advisory proposal regarding the Company's named executive officer compensation was approved as set forth below:”): 424,961,639 for, 50,924,101 against, per its Form 8-K filed 2026-05-08 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 575,800,000 outstanding shares: 74% for, 9% against (83% of the company cast a for/against vote).
The 1,029 asset managers below cast 92% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 91,426,980 | 645 | 7 | 0 | For |
| BlackRock | 46,354,925 | 2,187 | 0 | 0 | For |
| Fidelity | 39,154,139 | 59,407 | 0 | 0 | For |
| Wellington | 21,479,050 | 0 | 0 | 0 | For |
| State Street | 16,356,315 | 14,280 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 13,063,036 | 0 | 0 | 0 | For |
| JENNISON ASSOCIATES LLC | 11,576,980 | 0 | 0 | 0 | For |
| Invesco | 10,132,076 | 415,478 | 0 | 0 | For |
| Union Investment Management GmbH | 0 | 10,329,859 | 0 | 0 | Against |
| Ninety One UK Ltd | 8,365,922 | 0 | 0 | 0 | For |
| Walter Scott & Partners Ltd | 8,051,571 | 0 | 0 | 0 | For |
| JPMorgan | 7,855,737 | 0 | 0 | 0 | For |
| Charles Schwab | 6,936,802 | 0 | 0 | 0 | For |
| BROWN ADVISORY INC | 6,590,504 | 0 | 0 | 0 | For |
| T. Rowe Price | 6,530,801 | 50 | 0 | 0 | For |
| Northern Trust | 5,346,740 | 0 | 0 | 0 | For |
| WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST | 5,331,585 | 0 | 0 | 0 | For |
| Artisan | 4,518,276 | 0 | 0 | 0 | For |
| UBS | 0 | 3,562,210 | 0 | 0 | Against |
| PRIMECAP MANAGEMENT CO/CA/ | 3,422,791 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 3,234,566 | 0 | 0 | 0 | For |
| Neuberger Berman | 3,099,280 | 0 | 0 | 0 | For |
| APG Asset Management US Inc. | 3,039,896 | 0 | 0 | 0 | For |
| AllianceBernstein | 2,972,479 | 0 | 0 | 0 | For |
| Prudential/PGIM | 2,862,046 | 0 | 0 | 0 | For |
Showing the 25 largest of 1,029 asset managers. See all 1,029 in the interactive database.
Meeting held 2026-05-07.
Combines 3 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Edwards Lifesciences Corporation’s own tally for this item (“Proposal 4: The approval of the Company's Amended and Restated Long-Term Stock Incentive Compensation Program was approved as set forth below:”): 456,675,201 for, 19,210,539 against, per its Form 8-K filed 2026-05-08 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 575,800,000 outstanding shares: 79% for, 3% against (83% of the company cast a for/against vote).
The 175 asset managers below cast 99.7% of the shares they voted on this item FOR (195,567,032 for, 423,559 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 85,564,318 | 241 | 7 | 0 | For |
| Fidelity | 25,055,178 | 0 | 0 | 0 | For |
| BlackRock | 19,446,395 | 0 | 0 | 0 | For |
| Union Investment Management GmbH | 10,329,859 | 0 | 0 | 0 | For |
| JPMorgan | 7,252,190 | 0 | 0 | 0 | For |
| State Street | 6,473,545 | 84 | 0 | 0 | For |
| Invesco | 4,067,870 | 0 | 0 | 0 | For |
| Charles Schwab | 3,415,869 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 3,234,566 | 0 | 0 | 0 | For |
| Prudential/PGIM | 2,611,354 | 0 | 0 | 0 | For |
| TIAA | 2,564,689 | 0 | 0 | 0 | For |
| Waddell & Reed | 2,180,828 | 0 | 0 | 0 | For |
| Dimensional | 2,034,288 | 0 | 0 | 0 | For |
| BNY Mellon | 1,941,715 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,496,593 | 0 | 0 | 0 | For |
| Neuberger Berman | 1,141,109 | 0 | 0 | 0 | For |
| Allspring | 1,138,487 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 959,729 | 0 | 0 | 0 | For |
| Parnassus | 942,927 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 878,544 | 0 | 0 | 0 | For |
| Nationwide | 703,832 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 670,878 | 0 | 0 | 0 | For |
| Brighthouse | 472,793 | 0 | 41,639 | 0 | For |
| Cardano Risk Management B.V. | 495,588 | 0 | 0 | 0 | For |
| Putnam | 490,420 | 0 | 0 | 0 | For |
Showing the 25 largest of 175 asset managers. See all 175 in the interactive database.
Meeting held 2026-05-07.
Combines 5 wordings of this item as funds reported it.
89% Majority: yes · of votes cast
Edwards Lifesciences Corporation’s own tally for this item (“Proposal 3: Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 was approved as set forth below:”): 446,283,142 for, 56,814,075 against, per its Form 8-K filed 2026-05-08 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 575,800,000 outstanding shares: 78% for, 10% against (87% of the company cast a for/against vote).
The 168 asset managers below cast 99% of the shares they voted on this item FOR (183,461,769 for, 2,645,244 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 85,495,875 | 68,688 | 4 | 0 | For |
| Fidelity | 25,055,178 | 0 | 0 | 0 | For |
| BlackRock | 19,443,062 | 3,333 | 0 | 0 | For |
| JPMorgan | 7,252,190 | 0 | 0 | 0 | For |
| State Street | 6,473,545 | 84 | 0 | 0 | For |
| Invesco | 4,067,870 | 0 | 0 | 0 | For |
| Charles Schwab | 3,415,869 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 3,234,566 | 0 | 0 | 0 | For |
| Prudential/PGIM | 2,611,354 | 0 | 0 | 0 | For |
| TIAA | 2,564,689 | 0 | 0 | 0 | For |
| Waddell & Reed | 2,180,828 | 0 | 0 | 0 | For |
| Dimensional | 2,034,288 | 0 | 0 | 0 | For |
| BNY Mellon | 273,207 | 1,668,508 | 0 | 0 | Against |
| T. Rowe Price | 1,496,593 | 0 | 0 | 0 | For |
| Neuberger Berman | 1,141,109 | 0 | 0 | 0 | For |
| Allspring | 1,138,487 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 959,729 | 0 | 0 | 0 | For |
| Parnassus | 942,927 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 878,544 | 0 | 0 | 0 | For |
| Nationwide | 667,310 | 36,522 | 0 | 0 | For |
| Bridge Builder Trust | 670,878 | 0 | 0 | 0 | For |
| Brighthouse | 472,094 | 699 | 41,639 | 0 | For |
| Cardano Risk Management B.V. | 0 | 495,588 | 0 | 0 | Against |
| Putnam | 490,420 | 0 | 0 | 0 | For |
| Jackson National | 489,935 | 0 | 0 | 0 | For |
Showing the 25 largest of 168 asset managers. See all 168 in the interactive database.
Meeting held 2026-05-07.
Combines 8 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Edwards Lifesciences Corporation’s own tally for this item (“Elect Director: Leslie C. Davis”): 461,819,765 for, 13,184,241 against, per its Form 8-K filed 2026-05-08 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 575,800,000 outstanding shares: 80% for, 2% against (82% of the company cast a for/against vote).
The 167 asset managers below cast 99.6% of the shares they voted on this item FOR (185,531,577 for, 564,216 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 85,496,503 | 68,048 | 12 | 0 | For |
| Fidelity | 25,055,178 | 0 | 0 | 0 | For |
| BlackRock | 19,443,062 | 3,333 | 0 | 0 | For |
| JPMorgan | 7,252,190 | 0 | 0 | 0 | For |
| State Street | 6,473,629 | 0 | 0 | 0 | For |
| Invesco | 4,067,870 | 0 | 0 | 0 | For |
| Charles Schwab | 3,415,869 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 3,234,566 | 0 | 0 | 0 | For |
| Prudential/PGIM | 2,611,354 | 0 | 0 | 0 | For |
| TIAA | 2,564,689 | 0 | 0 | 0 | For |
| Waddell & Reed | 2,180,828 | 0 | 0 | 0 | For |
| Dimensional | 2,034,288 | 0 | 0 | 0 | For |
| BNY Mellon | 1,941,715 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,496,593 | 0 | 0 | 0 | For |
| Neuberger Berman | 1,141,109 | 0 | 0 | 0 | For |
| Allspring | 1,138,487 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 959,729 | 0 | 0 | 0 | For |
| Parnassus | 942,927 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 878,544 | 0 | 0 | 0 | For |
| Nationwide | 703,832 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 670,878 | 0 | 0 | 0 | For |
| Brighthouse | 472,793 | 0 | 41,639 | 0 | For |
| Cardano Risk Management B.V. | 495,588 | 0 | 0 | 0 | For |
| Putnam | 490,420 | 0 | 0 | 0 | For |
| Jackson National | 489,935 | 0 | 0 | 0 | For |
Showing the 25 largest of 167 asset managers. See all 167 in the interactive database.
Meeting held 2026-05-07.
Combines 9 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
Edwards Lifesciences Corporation’s own tally for this item (“Elect Director: David T. Feinberg, MD”): 473,746,144 for, 1,812,520 against, per its Form 8-K filed 2026-05-08 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 575,800,000 outstanding shares: 82% for, 0.4% against (83% of the company cast a for/against vote).
The 167 asset managers below cast 99.9% of the shares they voted on this item FOR (186,076,012 for, 19,791 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 85,564,542 | 19 | 5 | 0 | For |
| Fidelity | 25,055,178 | 0 | 0 | 0 | For |
| BlackRock | 19,446,395 | 0 | 0 | 0 | For |
| JPMorgan | 7,252,190 | 0 | 0 | 0 | For |
| State Street | 6,473,629 | 0 | 0 | 0 | For |
| Invesco | 4,067,870 | 0 | 0 | 0 | For |
| Charles Schwab | 3,415,869 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 3,234,566 | 0 | 0 | 0 | For |
| Prudential/PGIM | 2,611,354 | 0 | 0 | 0 | For |
| TIAA | 2,564,689 | 0 | 0 | 0 | For |
| Waddell & Reed | 2,180,828 | 0 | 0 | 0 | For |
| Dimensional | 2,034,288 | 0 | 0 | 0 | For |
| BNY Mellon | 1,941,715 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,496,593 | 0 | 0 | 0 | For |
| Neuberger Berman | 1,141,109 | 0 | 0 | 0 | For |
| Allspring | 1,138,487 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 959,729 | 0 | 0 | 0 | For |
| Parnassus | 942,927 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 878,544 | 0 | 0 | 0 | For |
| Nationwide | 703,832 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 670,878 | 0 | 0 | 0 | For |
| Brighthouse | 472,793 | 0 | 41,639 | 0 | For |
| Cardano Risk Management B.V. | 495,588 | 0 | 0 | 0 | For |
| Putnam | 490,420 | 0 | 0 | 0 | For |
| Jackson National | 489,935 | 0 | 0 | 0 | For |
Showing the 25 largest of 167 asset managers. See all 167 in the interactive database.
Meeting held 2026-05-07.
Combines 8 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Edwards Lifesciences Corporation’s own tally for this item (“Elect Director: Kieran T. Gallahue”): 457,045,403 for, 18,518,195 against, per its Form 8-K filed 2026-05-08 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 575,800,000 outstanding shares: 79% for, 3% against (83% of the company cast a for/against vote).
The 167 asset managers below cast 99.9% of the shares they voted on this item FOR (186,048,994 for, 46,808 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 85,564,289 | 271 | 5 | 0 | For |
| Fidelity | 25,055,178 | 0 | 0 | 0 | For |
| BlackRock | 19,446,395 | 0 | 0 | 0 | For |
| JPMorgan | 7,252,190 | 0 | 0 | 0 | For |
| State Street | 6,473,545 | 84 | 0 | 0 | For |
| Invesco | 4,067,870 | 0 | 0 | 0 | For |
| Charles Schwab | 3,415,869 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 3,234,566 | 0 | 0 | 0 | For |
| Prudential/PGIM | 2,611,354 | 0 | 0 | 0 | For |
| TIAA | 2,564,689 | 0 | 0 | 0 | For |
| Waddell & Reed | 2,180,828 | 0 | 0 | 0 | For |
| Dimensional | 2,034,288 | 0 | 0 | 0 | For |
| BNY Mellon | 1,941,715 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,496,593 | 0 | 0 | 0 | For |
| Neuberger Berman | 1,141,109 | 0 | 0 | 0 | For |
| Allspring | 1,138,487 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 959,729 | 0 | 0 | 0 | For |
| Parnassus | 942,927 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 878,544 | 0 | 0 | 0 | For |
| Nationwide | 703,832 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 670,878 | 0 | 0 | 0 | For |
| Brighthouse | 472,793 | 0 | 41,639 | 0 | For |
| Cardano Risk Management B.V. | 495,588 | 0 | 0 | 0 | For |
| Putnam | 490,420 | 0 | 0 | 0 | For |
| Jackson National | 489,935 | 0 | 0 | 0 | For |
Showing the 25 largest of 167 asset managers. See all 167 in the interactive database.
Meeting held 2026-05-07.
Combines 8 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Edwards Lifesciences Corporation’s own tally for this item (“Elect Director: Leslie S. Heisz”): 454,955,195 for, 20,567,869 against, per its Form 8-K filed 2026-05-08 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 575,800,000 outstanding shares: 79% for, 4% against (83% of the company cast a for/against vote).
The 167 asset managers below cast 99.9% of the shares they voted on this item FOR (186,064,453 for, 31,351 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 85,564,307 | 255 | 5 | 0 | For |
| Fidelity | 25,055,178 | 0 | 0 | 0 | For |
| BlackRock | 19,446,395 | 0 | 0 | 0 | For |
| JPMorgan | 7,252,190 | 0 | 0 | 0 | For |
| State Street | 6,473,629 | 0 | 0 | 0 | For |
| Invesco | 4,067,870 | 0 | 0 | 0 | For |
| Charles Schwab | 3,415,869 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 3,234,566 | 0 | 0 | 0 | For |
| Prudential/PGIM | 2,611,354 | 0 | 0 | 0 | For |
| TIAA | 2,564,689 | 0 | 0 | 0 | For |
| Waddell & Reed | 2,180,828 | 0 | 0 | 0 | For |
| Dimensional | 2,034,288 | 0 | 0 | 0 | For |
| BNY Mellon | 1,941,715 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,496,593 | 0 | 0 | 0 | For |
| Neuberger Berman | 1,141,109 | 0 | 0 | 0 | For |
| Allspring | 1,138,487 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 959,729 | 0 | 0 | 0 | For |
| Parnassus | 942,927 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 878,544 | 0 | 0 | 0 | For |
| Nationwide | 703,832 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 670,878 | 0 | 0 | 0 | For |
| Brighthouse | 472,793 | 0 | 41,639 | 0 | For |
| Cardano Risk Management B.V. | 495,588 | 0 | 0 | 0 | For |
| Putnam | 490,420 | 0 | 0 | 0 | For |
| Jackson National | 489,935 | 0 | 0 | 0 | For |
Showing the 25 largest of 167 asset managers. See all 167 in the interactive database.
Meeting held 2026-05-07.
Combines 9 wordings of this item as funds reported it.
90% Majority: yes · of votes cast
Edwards Lifesciences Corporation’s own tally for this item (“Elect Director: Paul A. LaViolette”): 428,701,646 for, 45,445,276 against, per its Form 8-K filed 2026-05-08 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 575,800,000 outstanding shares: 74% for, 8% against (82% of the company cast a for/against vote).
The 167 asset managers below cast 99.6% of the shares they voted on this item FOR (185,506,955 for, 588,826 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 85,496,043 | 68,496 | 27 | 0 | For |
| Fidelity | 25,055,178 | 0 | 0 | 0 | For |
| BlackRock | 19,443,062 | 3,333 | 0 | 0 | For |
| JPMorgan | 7,252,190 | 0 | 0 | 0 | For |
| State Street | 6,473,629 | 0 | 0 | 0 | For |
| Invesco | 4,067,870 | 0 | 0 | 0 | For |
| Charles Schwab | 3,415,869 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 3,234,566 | 0 | 0 | 0 | For |
| Prudential/PGIM | 2,611,354 | 0 | 0 | 0 | For |
| TIAA | 2,564,689 | 0 | 0 | 0 | For |
| Waddell & Reed | 2,180,828 | 0 | 0 | 0 | For |
| Dimensional | 2,034,288 | 0 | 0 | 0 | For |
| BNY Mellon | 1,941,715 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,496,593 | 0 | 0 | 0 | For |
| Neuberger Berman | 1,141,109 | 0 | 0 | 0 | For |
| Allspring | 1,138,487 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 959,729 | 0 | 0 | 0 | For |
| Parnassus | 942,927 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 878,544 | 0 | 0 | 0 | For |
| Nationwide | 703,832 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 670,878 | 0 | 0 | 0 | For |
| Brighthouse | 472,793 | 0 | 41,639 | 0 | For |
| Cardano Risk Management B.V. | 495,588 | 0 | 0 | 0 | For |
| Putnam | 490,420 | 0 | 0 | 0 | For |
| Jackson National | 489,935 | 0 | 0 | 0 | For |
Showing the 25 largest of 167 asset managers. See all 167 in the interactive database.
Meeting held 2026-05-07.
Combines 8 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Edwards Lifesciences Corporation’s own tally for this item (“Elect Director: Steven R. Loranger”): 446,216,434 for, 28,909,945 against, per its Form 8-K filed 2026-05-08 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 575,800,000 outstanding shares: 77% for, 5% against (83% of the company cast a for/against vote).
The 167 asset managers below cast 99.6% of the shares they voted on this item FOR (185,507,628 for, 588,168 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 85,496,271 | 68,283 | 11 | 0 | For |
| Fidelity | 25,055,178 | 0 | 0 | 0 | For |
| BlackRock | 19,443,062 | 3,333 | 0 | 0 | For |
| JPMorgan | 7,252,190 | 0 | 0 | 0 | For |
| State Street | 6,473,629 | 0 | 0 | 0 | For |
| Invesco | 4,067,870 | 0 | 0 | 0 | For |
| Charles Schwab | 3,415,869 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 3,234,566 | 0 | 0 | 0 | For |
| Prudential/PGIM | 2,611,354 | 0 | 0 | 0 | For |
| TIAA | 2,564,689 | 0 | 0 | 0 | For |
| Waddell & Reed | 2,180,828 | 0 | 0 | 0 | For |
| Dimensional | 2,034,288 | 0 | 0 | 0 | For |
| BNY Mellon | 1,941,715 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,496,593 | 0 | 0 | 0 | For |
| Neuberger Berman | 1,141,109 | 0 | 0 | 0 | For |
| Allspring | 1,138,487 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 959,729 | 0 | 0 | 0 | For |
| Parnassus | 942,927 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 878,544 | 0 | 0 | 0 | For |
| Nationwide | 703,832 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 670,878 | 0 | 0 | 0 | For |
| Brighthouse | 472,793 | 0 | 41,639 | 0 | For |
| Cardano Risk Management B.V. | 495,588 | 0 | 0 | 0 | For |
| Putnam | 490,420 | 0 | 0 | 0 | For |
| Jackson National | 489,935 | 0 | 0 | 0 | For |
Showing the 25 largest of 167 asset managers. See all 167 in the interactive database.
Meeting held 2026-05-07.
Combines 7 wordings of this item as funds reported it.
99.7% Majority: yes · of votes cast
Edwards Lifesciences Corporation’s own tally for this item (“Elect Director: Ramona Sequeira”): 474,260,552 for, 1,295,682 against, per its Form 8-K filed 2026-05-08 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 575,800,000 outstanding shares: 82% for, 0.3% against (83% of the company cast a for/against vote).
The 167 asset managers below cast 99.9% of the shares they voted on this item FOR (186,076,018 for, 19,786 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 85,564,548 | 14 | 5 | 0 | For |
| Fidelity | 25,055,178 | 0 | 0 | 0 | For |
| BlackRock | 19,446,395 | 0 | 0 | 0 | For |
| JPMorgan | 7,252,190 | 0 | 0 | 0 | For |
| State Street | 6,473,629 | 0 | 0 | 0 | For |
| Invesco | 4,067,870 | 0 | 0 | 0 | For |
| Charles Schwab | 3,415,869 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 3,234,566 | 0 | 0 | 0 | For |
| Prudential/PGIM | 2,611,354 | 0 | 0 | 0 | For |
| TIAA | 2,564,689 | 0 | 0 | 0 | For |
| Waddell & Reed | 2,180,828 | 0 | 0 | 0 | For |
| Dimensional | 2,034,288 | 0 | 0 | 0 | For |
| BNY Mellon | 1,941,715 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,496,593 | 0 | 0 | 0 | For |
| Neuberger Berman | 1,141,109 | 0 | 0 | 0 | For |
| Allspring | 1,138,487 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 959,729 | 0 | 0 | 0 | For |
| Parnassus | 942,927 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 878,544 | 0 | 0 | 0 | For |
| Nationwide | 703,832 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 670,878 | 0 | 0 | 0 | For |
| Brighthouse | 472,793 | 0 | 41,639 | 0 | For |
| Cardano Risk Management B.V. | 495,588 | 0 | 0 | 0 | For |
| Putnam | 490,420 | 0 | 0 | 0 | For |
| Jackson National | 489,935 | 0 | 0 | 0 | For |
Showing the 25 largest of 167 asset managers. See all 167 in the interactive database.
Meeting held 2026-05-07.
Combines 8 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Edwards Lifesciences Corporation’s own tally for this item (“Elect Director: Nicholas J. Valeriani”): 441,224,095 for, 34,327,820 against, per its Form 8-K filed 2026-05-08 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 575,800,000 outstanding shares: 77% for, 6% against (83% of the company cast a for/against vote).
The 167 asset managers below cast 99.7% of the shares they voted on this item FOR (185,662,351 for, 433,452 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 85,496,165 | 68,396 | 5 | 0 | For |
| Fidelity | 25,055,178 | 0 | 0 | 0 | For |
| BlackRock | 19,443,062 | 3,333 | 0 | 0 | For |
| JPMorgan | 7,252,190 | 0 | 0 | 0 | For |
| State Street | 6,473,545 | 84 | 0 | 0 | For |
| Invesco | 4,067,870 | 0 | 0 | 0 | For |
| Charles Schwab | 3,415,869 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 3,234,566 | 0 | 0 | 0 | For |
| Prudential/PGIM | 2,611,354 | 0 | 0 | 0 | For |
| TIAA | 2,564,689 | 0 | 0 | 0 | For |
| Waddell & Reed | 2,180,828 | 0 | 0 | 0 | For |
| Dimensional | 2,034,288 | 0 | 0 | 0 | For |
| BNY Mellon | 1,941,715 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,496,593 | 0 | 0 | 0 | For |
| Neuberger Berman | 1,141,109 | 0 | 0 | 0 | For |
| Allspring | 1,138,487 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 959,729 | 0 | 0 | 0 | For |
| Parnassus | 942,927 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 878,544 | 0 | 0 | 0 | For |
| Nationwide | 703,832 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 670,878 | 0 | 0 | 0 | For |
| Brighthouse | 472,793 | 0 | 41,639 | 0 | For |
| Cardano Risk Management B.V. | 495,588 | 0 | 0 | 0 | For |
| Putnam | 490,420 | 0 | 0 | 0 | For |
| Jackson National | 489,935 | 0 | 0 | 0 | For |
Showing the 25 largest of 167 asset managers. See all 167 in the interactive database.
Meeting held 2026-05-07.
Combines 7 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Edwards Lifesciences Corporation’s own tally for this item (“Elect Director: Bernard J. Zovighian”): 459,179,727 for, 16,257,009 against, per its Form 8-K filed 2026-05-08 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 575,800,000 outstanding shares: 80% for, 3% against (83% of the company cast a for/against vote).
The 167 asset managers below cast 99.9% of the shares they voted on this item FOR (186,075,790 for, 20,009 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 85,564,320 | 237 | 6 | 0 | For |
| Fidelity | 25,055,178 | 0 | 0 | 0 | For |
| BlackRock | 19,446,395 | 0 | 0 | 0 | For |
| JPMorgan | 7,252,190 | 0 | 0 | 0 | For |
| State Street | 6,473,629 | 0 | 0 | 0 | For |
| Invesco | 4,067,870 | 0 | 0 | 0 | For |
| Charles Schwab | 3,415,869 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 3,234,566 | 0 | 0 | 0 | For |
| Prudential/PGIM | 2,611,354 | 0 | 0 | 0 | For |
| TIAA | 2,564,689 | 0 | 0 | 0 | For |
| Waddell & Reed | 2,180,828 | 0 | 0 | 0 | For |
| Dimensional | 2,034,288 | 0 | 0 | 0 | For |
| BNY Mellon | 1,941,715 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,496,593 | 0 | 0 | 0 | For |
| Neuberger Berman | 1,141,109 | 0 | 0 | 0 | For |
| Allspring | 1,138,487 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 959,729 | 0 | 0 | 0 | For |
| Parnassus | 942,927 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 878,544 | 0 | 0 | 0 | For |
| Nationwide | 703,832 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 670,878 | 0 | 0 | 0 | For |
| Brighthouse | 472,793 | 0 | 41,639 | 0 | For |
| Cardano Risk Management B.V. | 495,588 | 0 | 0 | 0 | For |
| Putnam | 490,420 | 0 | 0 | 0 | For |
| Jackson National | 489,935 | 0 | 0 | 0 | For |
Showing the 25 largest of 167 asset managers. See all 167 in the interactive database.
Meeting held 2026-05-07.
Combines 2 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Edwards Lifesciences Corporation’s own tally for this item (“Proposal 4: The approval of the Company's Amended and Restated Long-Term Stock Incentive Compensation Program was approved as set forth below:”): 456,675,201 for, 19,210,539 against, per its Form 8-K filed 2026-05-08 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 575,800,000 outstanding shares: 79% for, 3% against (83% of the company cast a for/against vote).
The 9 asset managers below cast 87% of the shares they voted on this item FOR (727,407 for, 106,529 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Advisors' Inner Circle Fund III | 376,407 | 0 | 0 | 0 | For |
| Manitou Investment Management Ltd. | 184,906 | 0 | 0 | 0 | For |
| Maj Invest Holding A/S | 0 | 106,529 | 0 | 0 | Against |
| Empower | 96,718 | 0 | 0 | 0 | For |
| Erste Asset Management GmbH | 27,220 | 0 | 0 | 0 | For |
| WORMSER FRERES GESTION | 16,598 | 0 | 0 | 0 | For |
| Vontobel Holding Ltd. | 13,490 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 7,321 | 0 | 0 | 0 | For |
| Canopy Partners, LLC | 4,747 | 0 | 0 | 0 | For |
Meeting held 2026-05-07.
Combines 2 wordings of this item as funds reported it.
77% fund support · no official result
The 4 asset managers below cast 77% of the shares they voted on this item FOR (12,008 for, 3,512 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| NORTHERN LIGHTS FUND TRUST II | 11,183 | 0 | 0 | 0 | For |
| LEAVELL INVESTMENT MANAGEMENT, INC. | 0 | 3,512 | 0 | 0 | Against |
| MARCO INVESTMENT MANAGEMENT LLC | 800 | 0 | 0 | 0 | For |
| HARBOUR INVESTMENT MANAGEMENT LLC | 25 | 0 | 0 | 0 | For |
Meeting held 2025-05-08 (outside the 2025-2026 season's 1 July to 30 June window; reported in this season's filings).
Combines 2 wordings of this item as funds reported it.
88% Majority: yes · of votes cast
Edwards Lifesciences Corporation’s own tally for this item (“Proposal 2: The advisory proposal regarding the Company's named executive officer compensation was approved as set forth below:”): 412,893,480 for, 56,265,224 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 575,800,000 outstanding shares: 72% for, 10% against (81% of the company cast a for/against vote).
The 4 asset managers below cast 30% of the shares they voted on this item FOR (19,058 for, 45,178 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| OSSIAM | 0 | 35,018 | 0 | 0 | Against |
| Investment Management Corp of Ontario | 18,633 | 0 | 0 | 0 | For |
| PENSIOENFONDS RAIL & OV | 0 | 10,160 | 0 | 0 | Against |
| Philip James Wealth Mangement, LLC | 425 | 0 | 0 | 0 | For |
Meeting held 2026-05-07.
Combines 2 wordings of this item as funds reported it.
89% Majority: yes · of votes cast
Edwards Lifesciences Corporation’s own tally for this item (“Proposal 2: The advisory proposal regarding the Company's named executive officer compensation was approved as set forth below:”): 424,961,639 for, 50,924,101 against, per its Form 8-K filed 2026-05-08 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 575,800,000 outstanding shares: 74% for, 9% against (83% of the company cast a for/against vote).
The 3 asset managers below cast 100% of the shares they voted on this item FOR (99 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| National Philanthropic Trust | 0 | 0 | 0 | 0 | Not Voted |
| Fiera Capital Corp | 99 | 0 | 0 | 0 | For |
| IPConcept (Luxemburg) S.A. | 0 | 0 | 0 | 0 | -- |
Reported under meeting date 2026-03-10; no official results on file for that date.
0.1% fund support · no official result
The 2 asset managers below cast 0.1% of the shares they voted on this item FOR (394 for, 603,189 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| SCHRODER INVESTMENT MANAGEMENT GROUP | 0 | 603,189 | 0 | 0 | Against |
| GLOBALT Investments LLC / GA | 394 | 0 | 0 | 0 | For |
Meeting held 2026-05-07.
Combines 2 wordings of this item as funds reported it.
89% Majority: yes · of votes cast
Edwards Lifesciences Corporation’s own tally for this item (“Proposal 2: The advisory proposal regarding the Company's named executive officer compensation was approved as set forth below:”): 424,961,639 for, 50,924,101 against, per its Form 8-K filed 2026-05-08 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 575,800,000 outstanding shares: 74% for, 9% against (83% of the company cast a for/against vote).
The 2 asset managers below cast 100% of the shares they voted on this item FOR (855,586 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Empower | 852,847 | 0 | 0 | 0 | For |
| Arista Wealth Management, LLC | 2,739 | 0 | 0 | 0 | For |
Meeting held 2026-05-07.
All nominees (reported as one line). These filers reported the election of directors as a single line covering every nominee. It is not attributed to any one director, and no share total is shown for it.
100% fund support · no official result
The 2 asset managers below cast 100% of the shares they voted on this item FOR.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| NORTHERN LIGHTS FUND TRUST II | 11,183 | 0 | 0 | 0 | For |
| HARBOUR INVESTMENT MANAGEMENT LLC | 225 | 0 | 0 | 0 | For |
Ranked by the number of Edwards Lifesciences Corporation shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 575,800,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 15.88% |
| 2 | BlackRock | 8.05% |
| 3 | Fidelity | 6.81% |
| 4 | Wellington | 3.73% |
| 5 | State Street | 2.84% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 2.27% |
| 7 | JENNISON ASSOCIATES LLC | 2.01% |
| 8 | Invesco | 1.83% |
| 9 | Union Investment Management GmbH | 1.79% |
| 10 | Ninety One UK Ltd | 1.45% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| The Vanguard Group | 12.01% | DEF14A |
| BlackRock, Inc. | 7.69% | DEF14A |
| State Street | 4.57% | 13F |
| Wellington Management | 3.82% | 13F |
| JPMorgan Chase | 3.78% | 13F |
| BNY Mellon | 2.91% | 13F |
| FMR (Fidelity) | 2.52% | 13F |
| Morgan Stanley | 1.27% | 13F |
| Northern Trust | 1.01% | 13F |
| Mr. Ullem | 0.05% | DEF14A |
Percentages above are of 575,800,000 shares outstanding, as reported by Edwards Lifesciences Corporation on its Form 10-Q dated 2026-04-30 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Edwards Lifesciences Corporation’s 10-Q dated 2026-04-30. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At Edwards Lifesciences Corporation's shareholder meeting held 2026-05-07, in the 2025-2026 proxy season, 1,050 asset managers reported how they voted in their SEC Form N-PX filings, covering 11,720 separate fund positions. Their filings are grouped here into 19 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Advisory Vote to Approve Named Executive Officer Compensation — FOR was 89% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Edwards Lifesciences Corporation's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-05-08.
Edwards Lifesciences Corporation proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).